SLDB
Solid Biosciences Inc.
Solid Biosciences Inc. (SLDB) has 9 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 7, 2026.
Insiders have net sold $232K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Alexander G. Cumbo
- Employees:121
- HQ:Charlestown, MA, US
- IPO:2018-01-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$232K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$859.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Hanrahan JessieFirst filing | Chief Regulatory Officer | Sale | 4,134 | $24K | Feb 18 | SEC ↗ |
Ganot IlanFirst filing | Director | Sale | 2,658 | $15K | Feb 18 | SEC ↗ |
Tan KevinFirst filing | CFO & Treasurer | Sale | 5,404 | $31K | Feb 18 | SEC ↗ |
Cumbo AlexanderFirst filing | President and CEO | Sale | 16,644 | $97K | Feb 18 | SEC ↗ |
Herzich PaulFirst filing | Chief Technology Officer | Sale | 3,616 | $21K | Feb 18 | SEC ↗ |
Howton David TFirst filing | Chief Operating Officer | Sale | 7,469 | $43K | Feb 18 | SEC ↗ |
Related companies
Solid Biosciences Inc. is in the Healthcare sector.